Cartalax

Cartalax is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology — the same group behind Epithalon and other short-peptide bioregulators. While Epithalon was isolated from the pineal gland, Cartalax was derived from cartilage tissue and is hypothesized to act as a tissue-specific signaling peptide for the cartilage compartment. Preclinical research suggests Cartalax may stimulate chondrocyte proliferation, promote proteoglycan and collagen synthesis in articular cartilage, and support extracellular matrix remodeling in joint tissue. It is available from a small number of peptide research vendors, primarily as part of the Deadpool blend (BPC-157 + TB-500 + Cartalax) targeting joint and cartilage repair. Independent clinical data is scarce; its evidence base consists almost entirely of preclinical Russian-language studies from the Khavinson group.

Reconstitution

Reconstitute with 1–2 mL bacteriostatic water. Store refrigerated. Use within 30 days of reconstitution.